Washington, D.C. decriminalizes psychedelic plants
Voters in Washington, D.C. overwhelmingly approved Initiative 81, decriminalizing psychedelic plants. The measure does not legalize psychedelic plants and mushrooms, but recategorizes them «as the lowest priority of law enforcement by police», according to the initiative's wording.
The Initiative has been approved at 76%. It concerns plants containing :
- Ibogaine (Ayahuasca)
- Dimethyltryptamine
- Mescaline
- Psilocybin
- Psilocyne
The District of Columbia follows Denver, Colorado, Oakland and Santa Cruz (California) and Ann Arbor (Michigan) in the decriminalization of certain psychedelics.
Denver passed its initiative in May, while Oakland and Santa Cruz legislators passed their resolutions in June and February, respectively. The city council of Ann Arbor, Michigan, passed its measure in September.
None of these measures decriminalizing psychedelic plants include synthetic products such as LSD or MDMA.
Voters of the’Oregon legalized medical psilocybin in last night's general election and passed another measure decriminalizing all drugs.
The Washington initiative was started by Melissa Lavasani, a city government employee who used microdoses of psilocybin to help her recover from post-partum depression.
«Everyone knows, at least in the campaign, that I was hoping for 70% [of votes in favor]. [...] We've changed the game here. We've turned this dialogue into something people can feel, touch, see and hear. We're trying to normalize mental health, we're trying to normalize psychedelics, we're trying to normalize connecting with your community. The psychedelic movement was born on the West Coast, but DC tonight [voted] and showed that psychedelics play a major role in how we can heal as a community, how we can heal as a city and how we can heal as a country.» said Melissa Lavasani, on Facebook
-
Business4 weeks agoNew York Opens Its Farmers' Markets to Small-Scale Cannabis Producers
-
Cannabis in Africa4 weeks agoRwanda: A New License Revives the Country's Ambitions in Medical Cannabis
-
Cannabis in India4 weeks agoIndia Approves a Synthetic CBD Drug for Anxiety
-
Cannabis in Europe4 weeks agoThe EU Simplifies Regulations Governing Hemp Cultivation
-
Cannabis in the U.S.3 weeks agoU.S. Congress Comes to the Rescue of THC-Infused Beverages
-
Business4 weeks agoCuraleaf Announces a Takeover Bid for Aurora Cannabis
-
Cannabis in Europe3 days agoAndorra Paves the Way for Medical Cannabis Cultivation
-
Cannabis in France4 days agoDrought: Could Hemp Become the New Hope for French Farmers?



You must be logged in to post a comment Login